Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Colorectal Cancer|Metastatic Breast Cancer
Sponsor: University of Oxford
Collaborators: oxBRC|Vodafone UK Foundation|Centre for Statistics in Medicine|Oncology Clinical Trials Office (OCTO, Oxford)